Is Intentional Continuous Shallowing of the Anterior Chamber (ICSAC) a safe procedure? Does it cause endothelial cell damage?

Is Intentional Continuous Shallowing of the Anterior Chamber (ICSAC) a safe procedure? Does it cause endothelial cell damage? - ICSAC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35773

Enrollment

100

Registered

2011-08-24

Start date

2012-03-12

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole/pucker or vitreous opacity requiring vitrectomy

Interventions

ICSAC during vitrectomy versus no ICSAC during vitrectomy.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >= 18 years. - Informed consent. - Requiring vitrectomy for floaters, macular pucker or macular hole.

Exclusion criteria

Exclusion criteria: - Vitrectomy procedure is anticipated to be complicated. - ECD

Design outcomes

Primary

Measure	Time frame
Endothelial cell density at 1 and 3 months.	—

Secondary

Measure	Time frame
ECD at 6 months. IOP. Depth anterior chamber. BCVA. Complications.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)